ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000242.1|Lysolipin_1 # 2 # 175 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.701	BGC0000242.1|Lysolipin_1 	2	175	+	Loose	450	22.7126	ANT(9)-Ib	37.93	3007401	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(9)	ATCAGGGCCACCTTGCCCTCGAGTCGTCGTTTGGTCACGAATTCCGTCCTCCGAATGTGTCGACGGGTCGGTCGCTCACTGCTGCCCCGGGCCGGCCGGTCCGCCCGGGGAGTGGTCCTCCCGGCCGGATCGGTCGTGGCCCGGCCCCACTACGACGGCTCCTGCTTCCGGTAG	IRATLPSSRRLVTNSVLRMCRRVGRSLLPRAGRSARGVVLPAGSVVARPHYDGSCFR	MRRIYLNTYEQINKVKKILRKHLKNNLIGTYMFGSGVESGLKPNSDLDFLVVVSEPLTDQSKEILIQKIRPISKKIGDKSNLRYIELTIIIQQEMVPWNHPPKQEFIYGEWLQELYEQGYIPQKELNSDLTIMLYQAKRKNKRIYGNYDLEELLPDIPFSDVRRAIMDSSEELIDNYQDDETNSILTLCRMILTMDTGKIIPKDIAGNAVAESSPLEHRERILLAVRSYLGENIEWTNENVNLTINYLNNRLKKL	22.35	gnl|BL_ORD_ID|4912|hsp_num:0	5905			489	576	spectinomycin
BGC0000242.1|Lysolipin_3 # 554 # 1435 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.710	BGC0000242.1|Lysolipin_3 	554	1435	+	Loose	300	26.9498	dfrA12	26.19	3002858	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGGACGACAACCACCTGGGGGACTTCCTGCGCGCACGCCGCGCCGCCCTGCGCCCGCACGACGTCGGCATGCCGAGCCACGGGACCCGCAGAGTCGCCGGACTGCGCCGGGAGGAGGTCGCCGTCCTGGCCGGAGTGAACGCCGACTACTACACCCGCCTGGAACAAGGCCGCGAACGCAACCCCTCACCCCAGGTGATCGACGCCCTCGGTCACGCGCTGCGCCTCGACGAAGACGCCAGGACGCACCTGTACCGGCTGGCCGGGGCCACGCCCGGCGAACGGCCGTCCCCGCACTCCGCCGGGCGGGTCAGCCCCGCCTTGCGACAGCTGATGGACGGTTACCCCCATACCCCGGCGTTCGTCATGAACCGAACCCTCGACCTCCTCGCGGTCAACGCACTGGCCCAGGCCCTCTACTCGGCGTTCACCCCGGCGGACAACCTCGCCCGCATGATCTTCCTCGACCCCGCGGGCCCGGCCTTCTACACGGACTGGGACCGGGCGGCCCAAGCCGTCGTCGCCAACCTCCGCGAGGCGACCGGCTTCGCCCCGGACGACCCACGACTGCGCGAACTGGTCGGCACCCTCACCGAGCACAGCCCGGACTTCGCACGCCTGTGGCGGTCCCACACCGTGCGAGGCAAGACGCAGGACGCCAAGCGCTTCCTCCACCCGGACATCGGCCCCCTCACTCTCACCTACCAGGCCTTCGACGTACGCGAGACACCCGGCCGGCAACTCGTCATCTACCACGCCGAACCAGGAAGCCCCAGCGCCCAGTCCCTCAACTTGCTCGGCTCCCTGCACGCCACCCGGAGCCAGGCGGACTCCCCTCACGTCGCCGGCCATCCGATCCGACGTGGAGATCGGCACCGATAG	MDDNHLGDFLRARRAALRPHDVGMPSHGTRRVAGLRREEVAVLAGVNADYYTRLEQGRERNPSPQVIDALGHALRLDEDARTHLYRLAGATPGERPSPHSAGRVSPALRQLMDGYPHTPAFVMNRTLDLLAVNALAQALYSAFTPADNLARMIFLDPAGPAFYTDWDRAAQAVVANLREATGFAPDDPRLRELVGTLTEHSPDFARLWRSHTVRGKTQDAKRFLHPDIGPLTLTYQAFDVRETPGRQLVIYHAEPGSPSAQSLNLLGSLHATRSQADSPHVAGHPIRRGDRHR	MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPLPNRHTLVISRQANYRATGCVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFLSEVHQTFEGDAFFPMLNETEFELVSTETIQAVIPYTHSVYARRNG	177.58	gnl|BL_ORD_ID|1047|hsp_num:0	1139			210	456	trimethoprim
BGC0000242.1|Lysolipin_4 # 1390 # 1566 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGGGA;rbs_spacer=6bp;gc_cont=0.751	BGC0000242.1|Lysolipin_4 	1390	1566	-	Loose	525	22.7126	EFM-1	38.46	3006884	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	EFM beta-lactamase	GTGCGCGCCGTCCAGGAATGCCTGCAGGCCGTGCTGCGGAACGGCACGGTCGGCCCGGCCCCGCTCGGACACGGCCTGCCCGCGGAGCCGACCGCGGTGCCGCCGCAGTCCGGGCTGCGGCTCGGAGCGGTCTATCGGTGCCGATCTCCACGTCGGATCGGATGGCCGGCGACGTGA	MRAVQECLQAVLRNGTVGPAPLGHGLPAEPTAVPPQSGLRLGAVYRCRSPRRIGWPAT	MSARCLPALTLPLALAACAPPIQTPDPLPPREIVTPQQWAQQCTDWDEWDKPAPPYRIHGSTYYVGTCGIAAILVAGDGGHILIDSGTEAGADVVLDNVGKLGFRPNEIASLLHSHEHFDHTGGHALVRRESGAHVVASPQAAPVLRTGEDDPADPQHGLHDAMEPVPVDVIVRDGETVRSESATLTAIATPGHTPGALSWAWQSCDEAGDCLSIVYADSLSPISRKGYRFGDHPEYLEGFRAGLEKLRAVDCDILLTPHPSASDMVTRAAAGSMVGGMSCVDYADAVEARLDARLVEEAGD	19.21	gnl|BL_ORD_ID|3529|hsp_num:0	4598			432	549	
BGC0000242.1|Lysolipin_5 # 1922 # 2344 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.671	BGC0000242.1|Lysolipin_5 	1922	2344	+	Loose	700	24.6386	ADC-138	36.11	3006313	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	GTGCCCTGGACGGTCTCCGGTTCCACCCGCACTCCGCCCGGCCCCACTGGGGGGAGTCGAGAGCCGGACTTCTCGTACGCGAGCGTGAAAAGACCGGGGCAACGGGGCTTCCCGGTAGTCGGTTTGGACGGCACCCACAAGCTGCCGGCCGCGCTCTCGTGCGCCGACTCTCTCGATCAGGCGATCAAAAACTCTGTTCGACCGGATCGCCCCGCGTTCGATAAGCGGATGGCGTCCCGGCCCCCGGCGCAACGCTATTACGGGCGGGGTCACGTGTCATACAAACCAGAGCGGAAGCCAATTCCGCGGGAACACCCGGCCTTGGCGTACTTCCGTCGCCGAGTACCGGAGACAGCGCTTCCGTCCGCACGGACGGTCTTCGACCGTACGCGAGCACCCCTGCCCGCACAGTCCGGCTGGTGA	MPWTVSGSTRTPPGPTGGSREPDFSYASVKRPGQRGFPVVGLDGTHKLPAALSCADSLDQAIKNSVRPDRPAFDKRMASRPPAQRYYGRGHVSYKPERKPIPREHPALAYFRRRVPETALPSARTVFDRTRAPLPAQSGW	MRFQKVSCLLLSPLFIFSTSIYAGNTPKEQEIKKLVDQNFKPLLEKYNVPGMAVGIIQNNKKYETYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTLSFEDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNQSFDQVLEKTIFPDLGLKHSYVNVPKLQMQNYAFGYNQQNQPIRVNPGPLDAPAYGVKSTLPDMLSFINANLNPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPTVKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	36.55	gnl|BL_ORD_ID|3171|hsp_num:0	4209			516	615	
BGC0000242.1|Lysolipin_6 # 2830 # 4383 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGGAGA;rbs_spacer=4bp;gc_cont=0.695	BGC0000242.1|Lysolipin_6 	2830	4383	+	Loose	600	26.1794	TriB	32.69	3003680	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCATGCATTAGGCGTTCGCAGAATCCTGACGGCCGCGGGGGCGGCCCTCTCACTGGTGTACGGGACCTCGGCCGCCGCCGGCGCGGTCACGGGCTCCGGCACCACCGCCAAGACCGCCACCACCTACTACGTCGACTGCCGGGCGGGCAAGGACACCAACGCGGGCACGTCGTCCGCCGCGCCGTGGCGCACCCTCCGCAAGGTCGGGTCCAAGACCTTCCGGCCGGGCGACGTCATCGCCTTCCGCAAGGGCACGACCTGCAAAGGCACCCTCACACCGCACGGGTCCGGCACCGCGCGCCGTCCGATCTCGATCACCTCCTACGGCACCGGCGCGCGGCCCAAGCTGGTGGCCGATGACGCGCGAGCCGTGATCTACCTGCGCAATGTGCAGGGCTGGGAGATCCGCAACCTGGACATCTCCGACCCGGGCACCAACACCACCGACCCGCGCACCGGCATCTACGTCGAGCTGTCCGACTTCGGCGCCGGTTCGCACTACGTGTTCAGCAACAACTACATCCACGACGTGGGCGGCTGCGACTGCACCAACCCCGGCCAGCCGGGCGGCGGCATCGTGCTGAACGCCACCGGCTCGAAGACCGTGTCGTCGGTGTCGGACGTGAAGATCACCAACAACACACTGCGCACCGTCAACGGCATGGGCATCGGCACCTCCTCGTTGTGGCAGCGCCGCGCGGAGTACCCGTCCGGTCCGGGCACCGCCTACGGCGCCGACTACGGCATCGTGGTGCAGGGCAACGTCCTCAGCGACCTGGGCGGCGACGGGATCAACATCACCAACGGCCAGCACGCCCTGCTGCAGCACAACACGGTCGAGGGGTTCGGCCTGCGGGCGACCATCGACCACGCGGGAATCTGGGCGTGGAACTCGGACTACACGACCATCCAGCACAACACCATCGGCGGTGGCGACGCCGGCGCACTGGGCGCGTTCGCCTTCGACGTGGACGGCGCGAGCACCGGGACGCTCTACCAGTACAACTTCTCGCACGACAACAGCGGGCTGATGCTCATCTGCGCGCTCCCGGGCCTGCCGTCCGACCGGCCCACGATCCGCTACAACGTCAGCCAGAACGACCGTGACGCGTCCGGCGGTGTGGTGATCCTGGCCTGCGGCAGGCAGACCAACATCTCGATCTACGGCAACGACGTGTACGCGCCCACGGCGAAGACCATGTGGGTGAACGACAGCGACGGGGACACCCCGGCGGTCACGAACAACATCTTCGTCGGCAGGCCGGGCGGGTCGGCGTTCAAGGACACCCTCGGCACCTTCGACAGCAACCTCTACCGGCACATCACCTCGCCGCCGAGCGACCGGCACGCGGTGCTGGGCGACCCGGGCTTCGTCAGCCCCGGCACCGCGACGAGCGTCGTGGACGCCGCCGGGTACCGGCTCAAGAAGGGCGCGCCGGCACTGGGCGCGGGCGCGGCGATGCGCACCGACGCGCGCCGCGACTTCTACGGCAACCCCATCCCCGCCTGGCGCGCGAACATCGGCGCCTACCAGGGCTCAGGGGTGTCGTGA	MHALGVRRILTAAGAALSLVYGTSAAAGAVTGSGTTAKTATTYYVDCRAGKDTNAGTSSAAPWRTLRKVGSKTFRPGDVIAFRKGTTCKGTLTPHGSGTARRPISITSYGTGARPKLVADDARAVIYLRNVQGWEIRNLDISDPGTNTTDPRTGIYVELSDFGAGSHYVFSNNYIHDVGGCDCTNPGQPGGGIVLNATGSKTVSSVSDVKITNNTLRTVNGMGIGTSSLWQRRAEYPSGPGTAYGADYGIVVQGNVLSDLGGDGINITNGQHALLQHNTVEGFGLRATIDHAGIWAWNSDYTTIQHNTIGGGDAGALGAFAFDVDGASTGTLYQYNFSHDNSGLMLICALPGLPSDRPTIRYNVSQNDRDASGGVVILACGRQTNISIYGNDVYAPTAKTMWVNDSDGDTPAVTNNIFVGRPGGSAFKDTLGTFDSNLYRHITSPPSDRHAVLGDPGFVSPGTATSVVDAAGYRLKKGAPALGAGAAMRTDARRDFYGNPIPAWRANIGAYQGSGVS	MKPFSLAGLFGFALLLSGCGDEPPPAPPRPVLTVTVKTLKNDDLGRFAGSIQARYESVLGFRTNGRIASRLFDVGDFVGKGALLATLDPTDQQNQLRASQGDLASAEAQLIDAQANARRQEELFARSVTAQARLDDARTRLKTSQASFDQAKAAVQQARDQLSYTRLVTDFDGVITTWHAEAGQVVSAGQAVVTLARPEVREAVFDLPTEVAESLPADARFLVSAQLDPQARTTGSIRELGPQADASTRTRRVRLSLAQTPEAFRLGSTIQVQLSSAGSVRSVLPASVLLERDGKTQVWVVDGKQSSVALREVQVLSRDERQVVIGQGLADGDRVVRAGVNSLKPGQKIKLDEDAR	145.22	gnl|BL_ORD_ID|2003|hsp_num:0	2193			786	942	triclosan
BGC0000242.1|Lysolipin_8 # 5278 # 6654 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.687	BGC0000242.1|Lysolipin_8 	5278	6654	+	Loose	760	85.1149	tet(X3)	26.47	3004719	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGCCCGGACAACCCTTACACGTCATCATCATCGGCGCCGGAACCGGGGGCCTGTGCCTCGCGCAGGGACTGAAGCGGGCGGGTATCAGCGTCGCCGTCTACGAGCGCGACCGCACCCGCCGTGACGGGCTGCAGGGCTACCGGGTCGGCATCGACGCCGACGGCAAGCGTGCCCTGCGGGCCAACCTCTCCCCCGAGCTGTACAACACCTTCCTGGCCACATGCGCCCAACGGCCGGCCTACGGCAACCAGATGACGCATGAGATGAAGTGGCTCTTCTCCGCCGGGCCCGAGGTACTCAAGGAGGAGGACCGCCCGTCCGAGGACGACCAGGACGAGTCGGTGTCCCGGATGACGCTGCGTCAGGTGCTGCTGACCGGCGTCGAGGACGTCGTCCACTTCGACAAGGTGTTCACCCATTACGAGCAGCACCCGGACGGGCGGGTCACCGCCCACTTCGCCGACGGCGACTCGGCAACCGGCGACCTGCTGGTCGGCGCGGAGGGTGCCAACTCCAAGGTCCGCCAGCAGTATCTGCCGCACGCCAAGCTGGTCGACACCGGTCTGATCGGCATCACCGGCAAGACACCGCTGACCGACGAGACCCGCTCGCTGCTGCCCCAGCCCGTGATCGAGGGCGTCACGATGGTGCACGGCCCCAAGGGCTTCATGTGCATCTTCCACGTGATGCGCTTCAAGTGGGACCAGGACGGCCGGCCCCGGCAGGGAATCGGCAGCACGGACGCCGAGTTGATCGAGAACTGGCCCGGCATGCTGTACGACAACAGCCGCGACTACATCATGTGGGGCTTCGCCGCCTCCGACCAGTGGCTGCCGGAGGACGTCACCCGGATGCGCGGGGCGGAGCTCCAGAAGCTGGTGCTGGACCTGACCAGCGGCTGGCACCCGAACTTCCGCAGGATCTTCTCCCTGGGCGACCCGGGCAGCAGCTTCCCGCTGAAGATCCGCACGTCCGAGCCGATCCCCCGCTGGCGGTCCACCAATGTCACGCTGGTGGGTGACGCCATCCACACCATGACCCCCGGCCGGGGCGTGGGCGCCAACACCGCCCTGCGCGACGCCCGCCTGCTCACCCGCTGCCTGACGCGGGTGGCGGCCGGTGAAGTGCCGTTGCTGGAGGCGGTGCACGACTACGAGACGGAGATGACCGGCTACGCCTGGGACGCGGTCGTCAAGTCCCGGGCGCAGATGGACGGGCACTCGGTGATGCACCAGGGCGGCCTGGTAGGCAACCTGGCCCGGTTCGGCATGCGGACCGCCATGCGCACCATGAACCACCTGCCGCCGGTGAAACGCAAGATCGTCATGGCGGAGTCCACGTTCCGCGGCTCCGGCCGCGACGAGGACGAGGCCTGA	MPGQPLHVIIIGAGTGGLCLAQGLKRAGISVAVYERDRTRRDGLQGYRVGIDADGKRALRANLSPELYNTFLATCAQRPAYGNQMTHEMKWLFSAGPEVLKEEDRPSEDDQDESVSRMTLRQVLLTGVEDVVHFDKVFTHYEQHPDGRVTAHFADGDSATGDLLVGAEGANSKVRQQYLPHAKLVDTGLIGITGKTPLTDETRSLLPQPVIEGVTMVHGPKGFMCIFHVMRFKWDQDGRPRQGIGSTDAELIENWPGMLYDNSRDYIMWGFAASDQWLPEDVTRMRGAELQKLVLDLTSGWHPNFRRIFSLGDPGSSFPLKIRTSEPIPRWRSTNVTLVGDAIHTMTPGRGVGANTALRDARLLTRCLTRVAAGEVPLLEAVHDYETEMTGYAWDAVVKSRAQMDGHSVMHQGGLVGNLARFGMRTAMRTMNHLPPVKRKIVMAESTFRGSGRDEDEA	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL	118.04	gnl|BL_ORD_ID|4801|hsp_num:0	3401			51	1092	tigecycline; tetracycline
BGC0000242.1|Lysolipin_9 # 6706 # 6912 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.700	BGC0000242.1|Lysolipin_9 	6706	6912	-	Loose	1000	22.3274	MCR-8.2	44.0	3007229	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGGCGGTGACCATACCAGAGCAACCCCGCCGGCCCGTGCGGCGGGAATACGCCGACCGATGGCGCAACGCCGCCCGGCTGGCCATGGACATGCTGTCCACGTTCGGGATGTGCTACGTCGGTGTGCTGCTGACGCCACCGTACTGCCCGCCGGACGACGAGGAGGCCGGCGAGCAGTACGACCTGCCGGACGGCACCGGACGCTGA	MAVTIPEQPRRPVRREYADRWRNAARLAMDMLSTFGMCYVGVLLTPPYCPPDDEEAGEQYDLPDGTGR	MFKYLLSFKLNPVQRTWAAAFFFTTIGNIALWQTLWINVDVHNIHNLLFFVSLPIFLFCFLSILLTPVMVIPYLCRPLLVVLILISACCSYFMMKYNILIDRSMVQNFFETNQAELTSYLSVPFLSTLFLLGIVPAIILALPSTDNKRGAFRIELWWLAHICIAVVLLAMVTMVFYKDYASLIRNNMQIKDQALPFNFVRNTNGYLKRKYQASSTILQSVGEDAVRPIYSNSPPKLVVVVVGETARAQNFQLNGYSRVTNPYLSRRHDVISFKNVSSCGTATAISLPCMFSRMSRNEYNEVRAASEENLLDILKRTGVEVLWRNNNNGGCKGICKRVPTDDMPAMKVIGECVNKDGTCFDEVLLYQLSSRINAMQGDALIVLHQMGSHGPTYFERYPSTSKVFSPTCDSNLIEKCSNKELVNTYDNTLVYTDRMLSKTIELLQRYSGMRDVAMIYLSDHGESLGESGIYLHGTPYIIAPKEQTHIPMFMWFSSSFAQHSKLNLECLTGNADKQYSHDNFYHSILGLFNVKTSVYKPELDMFTLCRQSDHTPLSSAVVREKTDGNG	12.04	gnl|BL_ORD_ID|4849|hsp_num:0	5834			156	231	colistin A; colistin B
BGC0000242.1|Lysolipin_12 # 7600 # 8352 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.710	BGC0000242.1|Lysolipin_12 	7600	8352	-	Loose	450	83.5741	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	27.73	3004045	protein variant model	F203A	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGGATCTCGGTCTGACCGGCAAGAAAGCGCTCGTGACCGGCGGCACCCGCGGCATCGGCCGCGGCATCGTCCTGGCGCTCGCCCGGGCCGGCGCCGACGTCGTCACCTGCTACCGGCAGGACAGCGACGCGGTCGCCTCGCTGCAGGAGGAACTGAAGCAGACCGGCGGCAGCCATCACGTGCTGCGCGCCGACCTCGCCGACAGCGAGCAGGTCGCCGGACTGCTGGGCGAGTGCGCCGGCCGGCTCGGCCGGCTCGACGTCGTCGTCAACAACGCGGGCGTCATCAGCCACGTACCCTACGAAAAGCTGCCGCTGGACGAATGGCGGCGCGTCCTCGACACCAACCTCACCGCCGCCCACCTGGTCGTCCAGCACGCGCTGCCGCTGCTCTCCACGGGCGCGTCGGTGATCTCCATCAGCTCCAAGTCCTCCGAGGTGGGCATCCCGCTGCGCGCCCACTACACCGCCACCAAGGCGGCGCTGCGCGGCCTGAACCGCTCCCTTGCCAAGGAGTTCGGTCCAAAGGGCCTGCGCTTCAACGTCCTCGCGCTCGGTGTGATCGAGACCGAGGCCGTCGCCGCGATGAGTCCCGAGGAGGCCGCCGGACTGCGCGAGCGCTACGGCGCGAAGACCGCGCTGGGCCGCCTCGGCACACCCGACGAGGTGGCCGGCGCGGTGCTCTGGCTGGCCAGTGACCTCGCCACGTACGTCACCGGTGCCACCATCCACGTCGACGGAGGGATCTCCTGA	MDLGLTGKKALVTGGTRGIGRGIVLALARAGADVVTCYRQDSDAVASLQEELKQTGGSHHVLRADLADSEQVAGLLGECAGRLGRLDVVVNNAGVISHVPYEKLPLDEWRRVLDTNLTAAHLVVQHALPLLSTGASVISISSKSSEVGIPLRAHYTATKAALRGLNRSLAKEFGPKGLRFNVLALGVIETEAVAAMSPEEAAGLRERYGAKTALGRLGTPDEVAGAVLWLASDLATYVTGATIHVDGGIS	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	95.42	gnl|BL_ORD_ID|4712|hsp_num:0	2666			9	756	triclosan
BGC0000242.1|Lysolipin_13 # 8393 # 8854 # -1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GAGGG;rbs_spacer=8bp;gc_cont=0.732	BGC0000242.1|Lysolipin_13 	8393	8854	-	Loose	500	23.8682	GOB-23	33.33	3005672	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	GOB beta-lactamase	GTGCACACCGTCGTCGTCCCCCTGGTGCTGCTGGCCAACGGCCTCGCGGCCGGTGTACTGGTGGGCACCCAGCTCGGCGGGTGGCCGCTGCTCGCGGCACTGCCACCGGACCGCTACGTGCACGCCCACGCCTTCTTCGCCGGCCGCTACGACCCCTTCATGCCGGTCTGCTTCATCGGCACGCTGCTCGGGGACGTGCTGCTCGCGGGCGGCCAGGCACCTTGTGCGGCCCGGGTGCTGTTCGCGGTGGGCGCACTGCTCACGGCGACCGCCATGGTCGTCTCCGTCACCAAGAACGTCCCGGTCAACCGCTGGATCCGGACGCTGGACCCCGAGGCGCTCCCGGCCGACTTCGCCGGCCGGGACCCGCGGGCGAAATGGGGTGCCTGGAACCGCACCCGGTGCGTCCTGGCCGTCTTCGCGCTGCTGCTCAACGCCGCGGGCCTCGCCCTGGTGCTGTGA	MHTVVVPLVLLANGLAAGVLVGTQLGGWPLLAALPPDRYVHAHAFFAGRYDPFMPVCFIGTLLGDVLLAGGQAPCAARVLFAVGALLTATAMVVSVTKNVPVNRWIRTLDPEALPADFAGRDPRAKWGAWNRTRCVLAVFALLLNAAGLALVL	MRNFAILFFLSVCLSLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLPIIKGNIQKLGFNYKDIKILLLTQAHYDHTGALEDFKTETGAKFYADKADADVLKTGGKSDYEMGKYGVTFKPITPDRALKDQDKITLANTTLTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWVASHASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK	52.76	gnl|BL_ORD_ID|3567|hsp_num:0	4636			15	111	
BGC0000242.1|Lysolipin_14 # 8866 # 9333 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGGGA;rbs_spacer=7bp;gc_cont=0.673	BGC0000242.1|Lysolipin_14 	8866	9333	-	Loose	500	25.0238	NDM-42	30.26	3007219	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NDM beta-lactamase	ATGTCAGGACACACCGACAACTCGACCGTCATCGACGCACCGCTGGACCTGGTCTGGGACATGACCAACGACGTGGCCTCGTGGCCGGACCTGTTCAGCGAGTACGCCGAGGCCACCGTCCTGGAGCGGGACGGCAACCGGATCGTCTTCCGCCTGGCGATGCACCCGGACGCGGGCGGCACCGTGTGGAGCTGGGTGTCCGAACGCATCCTCGACCCGGTGGCCCGCACCGTCCACGCCCGCCGGGTGGAGACGGGCAACTTCAAGTACATGTGGCTGTTCTGGGAGTACACCACCGAGGACGACGGCGTACGGCTGCGCTGGGTGCAGGACTTCGAACTCAAGCCCGGCCTGCCCATGGACGATGCCGCGATGACCGACCGGCTCAACGCCAACTCGGTCGCCCAGCTCGAACTGATCAAGGAGAAGATCGAGGCCGTGGCCCGCGCGACCGCCGCCACACGCTGA	MSGHTDNSTVIDAPLDLVWDMTNDVASWPDLFSEYAEATVLERDGNRIVFRLAMHPDAGGTVWSWVSERILDPVARTVHARRVETGNFKYMWLFWEYTTEDDGVRLRWVQDFELKPGLPMDDAAMTDRLNANSVAQLELIKEKIEAVARATAATR	MELPNIMHPVAKLSTALAAALMLSGCMLGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR	57.41	gnl|BL_ORD_ID|4846|hsp_num:0	5830			171	387	
BGC0000242.1|Lysolipin_15 # 9336 # 9560 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=14bp;gc_cont=0.689	BGC0000242.1|Lysolipin_15 	9336	9560	-	Loose	400	24.6386	vanR gene in vanM cluster	44.44	3002928	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGCGCGACAGCATCGGCGTCGACGAGTCCGTCGACCTGACCGGAGCACAGGCCGACACCGACTTCGGCACCCTCGGCTACGACTCGCTGGCGGTGCTGGAACTGGCCGGCCGGATCCAGCGGATGCACGGCATCCCGCTGGCGGACGACGACCTGCTCACCGCGTCGACGCCACGTGAAGTCGTCGCGCTCGTCAACCGACACACCACCGAGGCGGGGATCTGA	MRDSIGVDESVDLTGAQADTDFGTLGYDSLAVLELAGRIQRMHGIPLADDDLLTASTPREVVALVNRHTTEAGI	MRRISILIAEDEEEIADLLAIHLEKEGYDVIKVHDGQEALHVIQAQSIDLIILDIMMPKMDGYEVTRQVRAQYNMPIIFLSAKTSDFDKVHGLVIGGDDYITKPFTPIELVARVNAQLRRSMKLNHPQADDKKSILEFGEIVISPDQRTVFLYGENIGLTPKEFDILYLLASHPKKVYSVENIFQQVWNDAYFGGGNTVMVHIRTLRKKLGEDKRKNKLIKTVWGVGYTFNG	31.90	gnl|BL_ORD_ID|4735|hsp_num:0	752			264	345	vancomycin; teicoplanin
BGC0000242.1|Lysolipin_16 # 9593 # 10837 # -1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=AGGGG;rbs_spacer=8bp;gc_cont=0.751	BGC0000242.1|Lysolipin_16 	9593	10837	-	Loose	750	105.531	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	30.85	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAGCGTTCCGCGCACCGCGGTCATCACCGGCATCGGCGTGACCGCGCCGACCGGTGTCGGGCTCGAGGCCCACTGGAAGTCCGTGCTGGGCGGCACGTCCGGCATCGGCCGGATCAGCCGTTTCGACCCCTCCGGCTACCCGGTCCGGCTCGCCGGTGAGGTGTCCGGCTTCGACGCGCCGCAGGCGGTCCCGCGCCGGCTGCTGCCCCAGACCGACCGGTGGACGCAACTCGCCCTGTGCGCGGCCGAGGAGGCCCTCGCCGATGCGGGCGTGGACCCCGCGGACCTCACCGACTACGACATGGCGGTGGTCACGGCCAGCTCCTCCGGCGGCACCGAGTTCGGCCAGCACGAGATGGAGCGCCTCTACCTCAAGGGCCCCTCGTGGGTGGGCGCCTACCAGTCGATCGCCTGGTTCTACGCCGCCACCACCGGGCAGCTCTCGATCCGGCACGGCATGCGCGGACCGTGCGGGGTGCTGTGCTGCGAACAGGCCGGCGGTCTCGACGCCATGGGCCAGGCCCGGCGGCTGATCCGCGACGGCTCACGGCTGGTGCTGACCGGCGGCACCGACGCCTCGTTGTGCCCGTACGGGCTCACCGCCCAGCTGGCCAACGGCCACCTGTCGACCGTCGAGGATCCGGCCCGCGCCTACCTGCCCTTCGACGCGGACGCCGCCGGCTACCTGCCCGGCGAGGGCGGGGCGATCCTCGTGGTCCGGGACGGCGCCGACGTCCCGCCCGGTGAGGGCTATGGAGTCATCCTCGGCTACGCGGCCGGGTTCGACCCGCCGCCGCACTCCGGCCGGCCGCCCGCGCTGCGCCGCACCCTGGAGCGGGCGCTCGCCGACGCGCGGGTGGAACCCGGCGACGTGGACGTGGTCTTCGCCGACGGCAGCGCGGTGCCCGAACAGGACATCGCGGAGGCCGAGGCGATCAACGCGGTCTTCGGGCGCGCCGCCGTGCCCGTGACGGTGCCCAAGACGCTCACCGGCCGGCTGTACGCAGGCGCCGCGGCACTCGACGCCGCCACCGCGCTGCTGGCGCTGCGCGACGGGGTCATCCCGCACACCGCGGCCACCACCCGGAAGGCACCGGGCTGCGACCTCGACCTGGTCCTGGGCGAACCCCGGTGGGGCCCGCTGCGCACGGCGGTGGTCCTGGCACGCGGGCACGGCGGCTTCAATGCGGCGCTGGTCCTGCAGCGGACCGGCGAGGCGAGCAAGGGAGGAGAGAGGCGTTGA	MSVPRTAVITGIGVTAPTGVGLEAHWKSVLGGTSGIGRISRFDPSGYPVRLAGEVSGFDAPQAVPRRLLPQTDRWTQLALCAAEEALADAGVDPADLTDYDMAVVTASSSGGTEFGQHEMERLYLKGPSWVGAYQSIAWFYAATTGQLSIRHGMRGPCGVLCCEQAGGLDAMGQARRLIRDGSRLVLTGGTDASLCPYGLTAQLANGHLSTVEDPARAYLPFDADAAGYLPGEGGAILVVRDGADVPPGEGYGVILGYAAGFDPPPHSGRPPALRRTLERALADARVEPGDVDVVFADGSAVPEQDIAEAEAINAVFGRAAVPVTVPKTLTGRLYAGAAALDAATALLALRDGVIPHTAATTRKAPGCDLDLVLGEPRWGPLRTAVVLARGHGGFNAALVLQRTGEASKGGERR	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	99.52	gnl|BL_ORD_ID|1968|hsp_num:0	1943			84	1245	isoniazid
BGC0000242.1|Lysolipin_17 # 10834 # 12123 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGGA;rbs_spacer=7bp;gc_cont=0.731	BGC0000242.1|Lysolipin_17 	10834	12123	-	Loose	1800	31.187	MexD	26.57	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCACACGCAGAGCCGCCATCACCGGCATCGGCGTGGTCGCGCCGGGCGCGGTGGGACGCGAGGCGTACTGGGACCTGCTGACCGCGGGCCGGACGGCGACCCGGCCCATCACGCTGTTCGACCCGGCTGGTTTCCGCTCCCGCATCGCCGCCGAGGTGGACTTCGACCCCTTCCGGGCCGGCCTGACCCACCGTCAGATACGCCGGATGGACCGCGCCGCGCAGTTCGCCGTGGTGTGCGTCCGCGAGGCGCTCGCCGACAGCGGCCTGGAACTCGCCGGCACCGCTCCCGAGCGCGTCGCGGTCAGCATCGGCAGCGCCGTCGGCTGCACCACGGGTCTGGAGGAGGAGTACCAGGTGCTGTCCGAGGACGGCCGTCGCTGGCTGATGGACCACACCTACGGCGTGCCGCACCTGTACGGCTACATGGTCCCCAGCTCGCTGGCCGTCGAGGTGGCCTGGGAGGTCGCGGCGGAGGGCCCGGTGGCGCTGGTCTCCACCGGCTGCACCTCCGGTCTCGACGCGGTCGGGCACGGCGCGCAGCTCATCGAGGAGGGCACCGCCGACATCGTGTTCGCCGGTGCCACCGACGCGCCGCTGTCCCCGATCACCTCCGCCTGCTTCGACGCCATCAAGGCCACCTCGCCCAACAACGACGACGCCGCCCACGCCTCCCGCCCGTTCGACGCCGAACGCGACGGCTTCGTGCTCGGGGAGGGCGCGGCGGTACTGGTACTGGAGGACGCCGCGGCGGCCCGGGCCAGGGGTGCGCGGGTCTACGCCGAGGTGGCCGGGTTCGCCAGCCGCAGCAACGCCTTCCACATGACCGGCCTGAAACCGGACGGCCGGGAGATGGCCGAGGCCATCACCCGGGCCCTGGACAAGGCCCGGCTGGACCCCTCCGCCGTGGACTACGTCAACGCCCACGGCTCCGGCACCCGCCAGAACGACCGGCACGAGACGGCGGCGTTCAAGCGCAGCCTCGGGGAGCACGCCTACCGGGTGCCGGTCAGCTCGATCAAATCCATGATCGGTCACTCGCTCGGCGCCATCGGCTCACTGGAGGTGGCGGCCTGCGCGCTCGCGCTGGAACGCCAGGTCGTGCCGCCCACGGCGAACCTGCACACCAAGGACCCCGAGTGCGACCTGGACTACGTGCCGCTGACCGCCAGGGAGCTCCCGGTCCGCACCGTGCTGAGCGTCGGCAGCGGCTTCGGCGGTTTCCAGAGCGCCACGGTGCTGGTCGGGGCCGGCGCTCGGCGCGGGGCGAAGGGGGGCCGTACGTGA	MTTRRAAITGIGVVAPGAVGREAYWDLLTAGRTATRPITLFDPAGFRSRIAAEVDFDPFRAGLTHRQIRRMDRAAQFAVVCVREALADSGLELAGTAPERVAVSIGSAVGCTTGLEEEYQVLSEDGRRWLMDHTYGVPHLYGYMVPSSLAVEVAWEVAAEGPVALVSTGCTSGLDAVGHGAQLIEEGTADIVFAGATDAPLSPITSACFDAIKATSPNNDDAAHASRPFDAERDGFVLGEGAAVLVLEDAAAARARGARVYAEVAGFASRSNAFHMTGLKPDGREMAEAITRALDKARLDPSAVDYVNAHGSGTRQNDRHETAAFKRSLGEHAYRVPVSSIKSMIGHSLGAIGSLEVAACALALERQVVPPTANLHTKDPECDLDYVPLTARELPVRTVLSVGSGFGGFQSATVLVGAGARRGAKGGRT	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	41.13	gnl|BL_ORD_ID|1485|hsp_num:0	1523			2085	2484	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0000242.1|Lysolipin_18 # 12120 # 12548 # -1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=AGGG;rbs_spacer=9bp;gc_cont=0.723	BGC0000242.1|Lysolipin_18 	12120	12548	-	Loose	300	29.261	AAC(3)-Ic	39.39	3002531	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGACCGCGGAGCGCAGGCTGAAGGTCAACGCGCGGGAGGTCTCCGCGAACCGCAGGCGCGGCGGAGAGCTGCGGGTGACCGTCAGCCCCAGGACGGTCGGCTGCACCTCCGGATTCGGCGGCCTGCTGAGGCTGGAGCCCGGTGAGTTCGTCACCGAGCACTACCACCCGTACTCCGAGGAGTTCCTGCACGTGATCTCGGGCCGGCTGGAGATGACCCTGGACGGCGAACCGGTCCGGCTCGGCCCCGGAGACTCGCTGTACGTCCCGATCGGGGTGCGGCACCGGCTGGTGAACACCGGCGACGAACCGGCGACCGGCGTGTTCCACCTCTCGCCCCTGGCACCGCGGCCCGAACTCGGCCACGTCGACACCGAGCCGGTGCCGGCGGCCGACGAGGCGCTACCGGACGTCGGGACCGCGACGTGA	MTAERRLKVNAREVSANRRRGGELRVTVSPRTVGCTSGFGGLLRLEPGEFVTEHYHPYSEEFLHVISGRLEMTLDGEPVRLGPGDSLYVPIGVRHRLVNTGDEPATGVFHLSPLAPRPELGHVDTEPVPAADEALPDVGTAT	MISTQTKITRLNSQDVGVMRAMLGMFGEAFEDAENYCRAQPSDSYLQDLLCGSGFIAIAALQGQEVIGGLAAYVLPKFEQQRKEIYIYDLGVQGAYRRRGIATALINELQRIAHDIGAYVIFVQADYGDDPAVALYTKLGIREDVMHFDIEPQPAA	91.03	gnl|BL_ORD_ID|1035|hsp_num:0	1131			375	468	astromicin; sisomicin; gentamicin
BGC0000242.1|Lysolipin_21 # 13825 # 14961 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGGGG;rbs_spacer=8bp;gc_cont=0.771	BGC0000242.1|Lysolipin_21 	13825	14961	+	Loose	700	51.9878	oleD	32.69	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGTGTGCTGTTCACGACCTGGGCGTGGCCTTCGCATCTGTACTCGCTGGTGCCGTTCGCCTGGGCGTGCCGCACGGCGGGACACGAGGTGCTGATAGCCGGCCAGCCGTCGCTGGCGGACGAGATCACGCGGTGCGGCCTGCCGGCGGCCCGGGTGGGAGGCGAGGTGGACGCCGTCGGCATGGTGCGCGGATATCTGCTGGGCCGGGCGTCCCCCGGGCGGGGCGGCGGGGGGCCGCGGGCCATGGAGATGTTCCGGGCACATGCCGACGCCATGCTCGACGACCTGGTGCGGCTGGCCCGCGACACCGAGCCGGACGTGGTGGTCTACGAGCCCACCGCGCTGGCCGGGCCGCTGGCCGCCGCCGCGGCCGGGGTGCCCTCCGTGCGGCACCTGTACGGCACGGACCTGATGGCGCGGGCCCGCGGCGTGCTGTCCCCGATGCTCGCCGAACTCGGCGCGCGGCACGGCATCCGCGGCGCCGATCCGTACGGCTCGGTGACCGTGGACCCGGTGCCGCCCGGCCTGCGGCTGCCTGCCGCACCCCCCGCGGTTCCGGTGCGGTACGTGCCGTTCAACGGCCCGGGCCGGGCGGTCGAGCTGCCGCCGCCGCTGCGGCCACGGGTGTGCGTCACCTGGGGTCACACGCTGGCGAAGCTGTCCGCGGACCGGTTTCTGGCGCCCGCGGTGGCCCGGGCGCTGGCCGTCTTGGACATCGAGGTGGTGGTGGCCGTCTCGGCGGCCCAGCAGGAACTGCTGGGCCCGCTGCCGGACGGGGTGCGGGTGGTGGTGGACGCGCCGCTGGACGGCGTGGTGCGCGACTGCGACCTGGTGGTCGCGCACGGCGGCGCCGCGACGGTGCTGACCGCGCTGTCCCACGGCGTCCCGCTGCTGCTCGTGCCGCAGCTGCCGGACCACGCCGGGCACGCCGCCCGGGTGGCCGCGGCCGGTGCGGGCGACCTGCTGCCCCATGACGCGGCGGGCCCGGAACGGCTCCGGGAGTACGTGGCACGGCTGCTCGGTGACGAGCGGTACCGGCAGGCGGCCCGCCGCCTGCGGCAGCAGATGCACGACCAGCCTCCGCCCGCGGCGCTCGCCGCAGACCTGCCGGCGACGGTCCGGTGCGCGGCGTGA	MRVLFTTWAWPSHLYSLVPFAWACRTAGHEVLIAGQPSLADEITRCGLPAARVGGEVDAVGMVRGYLLGRASPGRGGGGPRAMEMFRAHADAMLDDLVRLARDTEPDVVVYEPTALAGPLAAAAAGVPSVRHLYGTDLMARARGVLSPMLAELGARHGIRGADPYGSVTVDPVPPGLRLPAAPPAVPVRYVPFNGPGRAVELPPPLRPRVCVTWGHTLAKLSADRFLAPAVARALAVLDIEVVVAVSAAQQELLGPLPDGVRVVVDAPLDGVVRDCDLVVAHGGAATVLTALSHGVPLLLVPQLPDHAGHAARVAAAGAGDLLPHDAAGPERLREYVARLLGDERYRQAARRLRQQMHDQPPPAALAADLPATVRCAA	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	91.08	gnl|BL_ORD_ID|1253|hsp_num:0	1367			831	1143	erythromycin; tylosin
BGC0000242.1|Lysolipin_22 # 14993 # 16837 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGAGA;rbs_spacer=12bp;gc_cont=0.732	BGC0000242.1|Lysolipin_22 	14993	16837	+	Loose	450	27.7202	aadA	51.72	3002601	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGTGTGGCGTAGCCGGATGGATCGACTTCGAACGCGACCTGTCCGAGCACGGCAGCACCGTGCGCACGATGGCCGCCACCCTGGCCAACCGCGGCCCGGACGCCGAGGCGGTGTGGACCGGCCGGTGCGCGGCGCTGGCGTTCCGCCGGCTCGCCGTCATCGACCTGCCCGGCGGCGGCCAGCCGATGGTCGCCGAGGAGGACGGCAGGCAACTGGCGGTGCTCGTCTACAACGGCGAGGTCTACAACTACCGCACGCTGCGCGACGAACTGGCGGCGCGCGGGCACCGGTTCCGCACGGCGAGCGACACCGAAGTGGTGCTGCGCGCCTATCTGGAGTGGGGCGGCGCGTGCGTCGAGCACCTCGACGGGATGTTCGCCTTCGCGGTGTGGGATCCGCGCCGCCGGGAACTGCTGCTCGCCCGCGACCGGCTCGGTGTGAAACCGCTGTACTACGCGCGGGTGGGGTCCGGCATCGTCTTCGGTTCCGAGGTGAAGGCGCTGCTGGCACACCCGCTGGTGGAGCCGGTGGTGGACGCCGAGGGCCTGGCCGAGCTGCTGTCGTACATCGCCACCCCGGGACACGCGATCTACCGGGGCATCAGGGAGGTGCGGGCCGGGCACACGCTGACCGTCCGGGACGGTGCCGTGCGGGAACGCGCCTACTGGACGCTGCCCAGCCGGGAACACCGCGACGACTGGGACACCACCGTGGAGACGGTGCGCCACCTGCTCACCGAGTCGGTGGCCTCGCACCTGGTGGCCGACGTCCCGCTGTGCACGCTGCTGTCCGGCGGCATCGACTCCAGCGCGATCGCGGCGCTGGCCGCCCGGCGGCAGGACACCCCGCCGCGCACCTTCGCCGTCGACTTCGAGGGCCACACCGAGCGGTTCCGCGAGGACCGCTGGCACCGCACCCCCGACGCGCCGTACGCCGCCGAGGTGGCGCGGTTCGTCGGCACCGACCACCGTCCGGTGGTGCTGCGCACCGCGGACCTGGCCGACCCGGTGATCGGGACGGCGGCGCTGACCGCCCAGGACCTGCCGCGGCCCACCCCCGACATGGACAGCTCGCTGTACCTGCTGCTGCGCGCGGTGCGGCAGCACTCCACCGTGGCGCTGATGGGCGAGACCGCCGACGAACTGTTCGGCGGCTACCGGTGGTTCGGCGACCGGGAACTCGTCGACAGCGGCAACTTCCCGTGGGTGACGATGGGTTTCTCGGTCGCCCCGCACGGCATGAGCACCGGCCTGCTCGATCCGGCGCTGCTGGAGAAGGTGGACGTGCCCGGCTACTCGGCCGGCCGCTACGCGGACGCGGTGCGGGAGGTGACGGAGGTGCCCGGCGAACCGGAGCGGGACGCGCTGCTGCGCCGCGCCGGCTACCTGCACATGACGCGCTGGCTGCCGCTGCTGCTGACCCGCAACGACCACCTGGGCATGGCCGTGGGCCTGGAGGTGCGGGTGCCGTACTGCGACCACCGGCTGGTGGAGTACGTGTTCAACATCCCCTGGCGGTTCAAGGCCCGCGGCGGCGAGGAGAAGAGCCCGCTGCGTGCCGCGATGGCCGGGCTGCTGCCGGAGTCGGTGCTGCGCCGCAGCAAGAGCCCGTTCCCCGTCACCCAGGACCCCGGATACGGAGCGGTGCTGCGCGACCGGCTGGCAACAGTGGCGGCCGACCCGGCGAGCCCGGTGCGCCCGCTGCTGGACACCGCTGCGGTGGACCGGCTGCTCACGGCCGGCCGGCCGGTGGACACCACCGGCTGGGGCGAGCGGCGCGATGTGGAGATGGTGCTGCAACTCGACGCCTGGCTGCACCGCTACGCGGTGCGCCTGGCGCTGTGA	MCGVAGWIDFERDLSEHGSTVRTMAATLANRGPDAEAVWTGRCAALAFRRLAVIDLPGGGQPMVAEEDGRQLAVLVYNGEVYNYRTLRDELAARGHRFRTASDTEVVLRAYLEWGGACVEHLDGMFAFAVWDPRRRELLLARDRLGVKPLYYARVGSGIVFGSEVKALLAHPLVEPVVDAEGLAELLSYIATPGHAIYRGIREVRAGHTLTVRDGAVRERAYWTLPSREHRDDWDTTVETVRHLLTESVASHLVADVPLCTLLSGGIDSSAIAALAARRQDTPPRTFAVDFEGHTERFREDRWHRTPDAPYAAEVARFVGTDHRPVVLRTADLADPVIGTAALTAQDLPRPTPDMDSSLYLLLRAVRQHSTVALMGETADELFGGYRWFGDRELVDSGNFPWVTMGFSVAPHGMSTGLLDPALLEKVDVPGYSAGRYADAVREVTEVPGEPERDALLRRAGYLHMTRWLPLLLTRNDHLGMAVGLEVRVPYCDHRLVEYVFNIPWRFKARGGEEKSPLRAAMAGLLPESVLRRSKSPFPVTQDPGYGAVLRDRLATVAADPASPVRPLLDTAAVDRLLTAGRPVDTTGWGERRDVEMVLQLDAWLHRYAVRLAL	MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	233.46	gnl|BL_ORD_ID|591|hsp_num:0	650			378	462	spectinomycin; streptomycin
BGC0000242.1|Lysolipin_23 # 16870 # 17538 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AGAGA;rbs_spacer=8bp;gc_cont=0.734	BGC0000242.1|Lysolipin_23 	16870	17538	+	Loose	700	26.1794	MOX-5	32.81	3002188	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	MOX beta-lactamase	ATGCTGCACGACGAACTGGTGGAGCTCGCTGCTCCGGTGCTGCGCAAGGTGCTGGACCATCCCTTCTGGAGCGGACTGCGGGACGGCTCGCTGCCCGGTGAGGCGCTCGTGCACTTCGTCGAGCAGGACACCGGGCACCTGCTGCCCGCCTACGGCCGGGCGCTGGCGCGGTGCGCGGCGACCGCCCACGACGACGCGCACGCGGTGTTCTTCGCCCGGGCCGCGGTCGGCACGCTGGAGGCCAGGAACCGGCTGCGGGAGGAGTTCACCGGCCTGCTGCCCCGCCTCGGCCTGCCGGCGCCGTCCGCCCACGTGCCCGCGGATCCCCTCGCGCACGCGCACTGCGCCTTCTTCCACGCAGCGGCGGCGACCTCGCTCGCCGCCGGGGCCGGTGCGGTGCTGCCGATGGCCTGGTTCAACCTCCAGGTGTCCAAGGACCTGGCGGAGCGTCGCACGCGCGGCTCGGTGTACGAGCCGTGGATCGAGCTGTACCAGCCCTCCGAGGGCTACGCCCGCGTCGTCGAGCGCTATCTCGCGGTCGTCGACGAGATCGGCGAGCAGTGCTCCGCCAGGGAGCGCGAGCAGCTCGTCGAGTCCTTCCAGACCGGCATCCGCCACGAGTGGGCGTTCGCCGAGAGCGCCTGGCAGCGACCGGCCTGGCCGGTGTGA	MLHDELVELAAPVLRKVLDHPFWSGLRDGSLPGEALVHFVEQDTGHLLPAYGRALARCAATAHDDAHAVFFARAAVGTLEARNRLREEFTGLLPRLGLPAPSAHVPADPLAHAHCAFFHAAAATSLAAGAGAVLPMAWFNLQVSKDLAERRTRGSVYEPWIELYQPSEGYARVVERYLAVVDEIGEQCSAREREQLVESFQTGIRHEWAFAESAWQRPAWPV	MQQRQSILWGALATLMWAGLAHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGGFELDDKASLFAPWLKGSAFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSRGSHRQYANPSIGLFGYLAASSMKQPFDRLMEQTMLPGLGLYHTYLNVPEQPMGHYAYGYWKEDKPFRVTPAMLAEEPYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYPYPVSEQTLLAGNSPAMIYNANPAAPAPAAAGHPVLFKKTGSTNGFGAYVAFVPAKGIGVVMLANRNYPNEGTLKAGHAILTQLAR	57.96	gnl|BL_ORD_ID|43|hsp_num:0	53			489	666	
BGC0000242.1|Lysolipin_24 # 17573 # 18781 # 1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=AGAGA;rbs_spacer=11bp;gc_cont=0.688	BGC0000242.1|Lysolipin_24 	17573	18781	+	Loose	730	26.9498	mexX	31.88	3003034	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACGACTCAGTCCCCCGTTCGCTATCCCTTCCCGTGGACACCGCCGATGGAGATCCCGGAGGCCCTGCGCGGTCTGCGGGAGCACTCGGCGGTCCAGGTGACGCTGCCCAGCGGTGACACGGCCCTGATGGTCACCCGTTACAAAGACGTGCGCGCCCTCTTCGCCGACCACCGGCTGAGCCGGAACATCTCCCGTCGGCAACGGCCGGACGTCGCGCGGATCTCCGCCGACAACGAGCTGTTCGCCGACCCGGAGATCAACCCGGACCCGCCGGACCACATCCGGGTCCGCGGCCTGGTCACCCGCGCCTTCACCGCCCGTCGCGTGGAGGCGCTGCGCCCGGTGGCGCAGGGCATCTGTGACGAGCTGATCGACGCGATGGAGGCCGGCCCGCGCCCGGTCGACCTCAACGAGGCGTTCGCCTTCCCGCTGCCGATCCGGGTGATCTGCCGGCTGCTGGGAGTGCCCGCCGAGGACATGGACACCTTCCGCTACCTCGTCGACGGCTTCCTGTCCGTCACCAAACTGCCGGTCGAGGAGATGCAGAAGTGCCGGGAGGGCCTGTGGAACTACCTCGGCGAACTGATCGAGTCCAAGCGCGGGGAGCCGGGTGACGACCTGATCAGCGGTCTGATCAAGGTCCGCGACGAGGACAACAACCGGCTGTCGGAGCACGAGCTGCAGTTCTGGACGCAGGGCCTGCTGATCGCCGGCTATGTGACGACGGCGAGTCAGATCGGGGCCAGCGCGGCCGTCCTGCTGCACCACCGGGACCTGGTCAAGGAGATCCAGGCGGACTGGTCCCTGGTGCCCGGCGCGGTGGAGGAGCTGCTGCGCACCCAGATCATGGGTTCCTCGATCGGCACCCTGCGGTACGCCGTGGACGACATCCCGCTCTCCGACGGATCGGTGATCAAGAAGGGCACCAGTGTCCTGCTGTCCGAGGAGTCGGCCAACATGGACGAGGAGGTCTTCGCCGAGCCTTTCAAGATCGACATCCGGCGGACCGACAACCACCACATGACGTTCGGGGCCGGCCTGCACTACTGCGCCGGTGCGGCACTGGCCCGCATGGAGCTGCAGGTGGCCACCCGGACGCTGCTGGAGCGGCTGCCGGACATCGCCCTGGCCGTTCCGGGCGAGCGCCTGCCGCGCGCCCTGGGCGGCTTCACCGAGGGCTTCACCCAGATCCCTGTCACCTGGTAG	MTTQSPVRYPFPWTPPMEIPEALRGLREHSAVQVTLPSGDTALMVTRYKDVRALFADHRLSRNISRRQRPDVARISADNELFADPEINPDPPDHIRVRGLVTRAFTARRVEALRPVAQGICDELIDAMEAGPRPVDLNEAFAFPLPIRVICRLLGVPAEDMDTFRYLVDGFLSVTKLPVEEMQKCREGLWNYLGELIESKRGEPGDDLISGLIKVRDEDNNRLSEHELQFWTQGLLIAGYVTTASQIGASAAVLLHHRDLVKEIQADWSLVPGAVEELLRTQIMGSSIGTLRYAVDDIPLSDGSVIKKGTSVLLSEESANMDEEVFAEPFKIDIRRTDNHHMTFGAGLHYCAGAALARMELQVATRTLLERLPDIALAVPGERLPRALGGFTEGFTQIPVTW	MDRLAARLLAALVALFLLGCEEAADAGKTAEAPAEVGVIVARPAPIGITSELPGRLEAYRQAEVRARVAGIVTRRLYEEGQDVRAGTVLFQIDPAPLKAALDISRGALPGRGQPRAAADKLKAYADLIKDRAISEREYTEAQTDARQALAQIASAKAELEQARLRLGYATVTAPIDGRARRALVTEGALVGEDSPTPLTRVEQIDPIYVNFSQPAAKSRHAAGDPRRPGEGCRRQGHRRAPGPGRRQRVPLAGELLFIDLAVDPGTDTIAMRALFRNPHRELLPGGYVQVRLQRAVNPQAITVPDALIRTAQSAVVKVVNPKGLVEDVEVRADTLQGRDWIISRGLKGGEWVIVENAAQHAAGSSVQAVVRQPASADAPSPLAASPAGQ	103.34	gnl|BL_ORD_ID|306|hsp_num:0	334			57	258	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
BGC0000242.1|Lysolipin_27 # 19428 # 20273 # -1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=4bp;gc_cont=0.788	BGC0000242.1|Lysolipin_27 	19428	20273	-	Loose	500	27.335	OXA-114g	27.59	3005707	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGATCACCGTGTTCGGAGCCACGGGCAACGTCGGCCGCGAGGTGGTGTCCCTGCTGACCGCCGCGGGCGGCCCGGTGCGCGCCGTCACCCGCGACCCCTCCCGGGCCGGATTCGGCGCCGGGATCGAGGTGGTGCGCGGCGACCCGGGCAGGCCGGGCGACGCCCGGCGCGCCCTGGCCGGCGCGGACGCCGCGTTCGTGGTGACCGCGGGCCCGGACGCCCCGGCCCACGCGCTGGCCATCGCCCAGGCGGTGCGCCGGTGCGGCACCGGGCGCGTGGTGACGGTGTCCTCGGTCGCGGCGATGGAACCGGTGACCAACGCCTACGGCGCCGCGCACGCCGAGGCCGAGCGGGCGTTCCGGGACTGCGGGGCCGCCTGGACGCTGCTGCGTCCCGCCGCCTTCATGTCCAACACCCTGCAGTGGCTGTGGTCCCTCGGCTCCGAGGGCCGCGTCTACCAGCCCTACGGGGAGCTCCCGCAGGCCGTGGTGGACCCGGCGGACGTCGCCGAGGTCGCCGTGCGGGCGCTGACCGGTCCGGGACACGAGGGCCGCGTCCACACCCTCACCGGCCCCCAGGCGCTCACCGGGCGGGACCGGGCACGGCTGCTCGCGACCGCCCTCGGCCGTCCGGTGGAGTTCGTCGACGCGCCCCCGCGGGCGGCGAAGGAGGCCATGGTCGCCGCCGGGCTGCCGGCCGGGTACGCCGAGGCGCTGCTGGCCGCCCAGGGCGATCCGGACCCGGCTCGCGGCGGTGTGCCGCTGCCGACCGTCGCGGAGGTCACCGGCCGCCCGCCGCGCACCTTCGCCGACTGGCTCGCCCGCCACCTGCACCGGTTCGCCTGA	MITVFGATGNVGREVVSLLTAAGGPVRAVTRDPSRAGFGAGIEVVRGDPGRPGDARRALAGADAAFVVTAGPDAPAHALAIAQAVRRCGTGRVVTVSSVAAMEPVTNAYGAAHAEAERAFRDCGAAWTLLRPAAFMSNTLQWLWSLGSEGRVYQPYGELPQAVVDPADVAEVAVRALTGPGHEGRVHTLTGPQALTGRDRARLLATALGRPVEFVDAPPRAAKEAMVAAGLPAGYAEALLAAQGDPDPARGGVPLPTVAEVTGRPPRTFADWLARHLHRFA	MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGRHNGTDGAWIISSLRISPLEQLAFLRKVVNRQLPVKAAAYELADNLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVYARLLQDERATQPNAGLRARDELVRDWPAMAGAWRP	102.18	gnl|BL_ORD_ID|3737|hsp_num:0	4807			399	624	cloxacillin; oxacillin; cefalotin
BGC0000242.1|Lysolipin_28 # 20270 # 21463 # -1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.768	BGC0000242.1|Lysolipin_28 	20270	21463	-	Loose	800	69.707	tet(48)	24.58	3004581	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGGCGTCATACCCCGAGCGGCACGCCGTGGTCGTGGGCGCGGGCATCGGCGGACTGGCCGCCGCCGTCGCACTGGTCCGCGTGGGCTGGCACGTCACCGTCTACGAACGTGCCCCCGAGCTGCGGACCGAGGGCGCGGGCATCTCCCTGCTGTCCAACGCCGTGCGGTCGCTGGACCGGCTGGGCGCCGGCGACGCGGTGCGCGCCGCCGCCGCCGTGATGCTGCCGGGCGGGGAGGGCGTGCGCACCCCGTCCGGGCGGCGGCTGATGAAGCCGGCCGACCCCTCGTTCGTCAGCCGGCACGGTCTGTCCACCCTGGTCCTGCCACGGCCGGCGCTGCACCGGGCGCTGTACGACGCCCTGCCCGCCGACTGCGTACGCACCGGCACGGAGGTGCTGCGGCTGGCCGGCCCGCCGGCCGGGCCGGTGGAGGTCAGCTGCCGGGACGCGGCCGGCGAACACACCGTGCCGGCCGGCCTGGTGGTCGCCGCCGACGGCACGCACAGCCGGATCCGCCGCGCCCTGTGGCCCGCCGTGGCCGCTCCCGCCTACAGCGGGCACAGCGTCTGGCGCGGCATCGCCCGGCTCGACCGCAGTGAGCCGGGCGGCACCACGTGGGGCTGTGGCCAGGAGTTCGGCCGCATGCCGCTGCGGGACGGCCGGGTCTACTGGTACGCCGTCGCCAACACCCCGCCCGGCCGGCGCCATCCCGACGAACTGGCCGAGGTGGTGCGACGGTTCGGCACCTGGCACCACCCGATCCCCGCGCTGCTGCGCGCCACCCCGGCGGACGAGGTGCTGCACCACGACGTCTTCGAACTCGCCCAGCCGCTGCCCGGCTACGCCAAGGGCGTCACCGCCCTGCTCGGCGACGCCGCCCACGCCATGACCTCCGACCTGGGCCAGGGCGCCTGCCAGGCCCTGGAGGACGCCGTGGTGCTGGGCGCCGAACTGGCCGCCGACTCCGACGTGCCGACGGCACTCGCGCGCTACGACGCCCAGCGCCGCCCGCGGGCCCAGACGGTCGTCGAGGCCTCCCGCCGGATGGGGCGGCTGAAACTGCGTGAACGCTGGTGGGACGTGCTGATGCGCAACGCGCTGATCAGCGTCATGCCGCCACGGGCCGGGGAGAAGGCGATGGCCCGCATCGGCGACTGGCACCCCCCGGCCCTGCCCGCCCGGGAGGCGCCGTGA	MASYPERHAVVVGAGIGGLAAAVALVRVGWHVTVYERAPELRTEGAGISLLSNAVRSLDRLGAGDAVRAAAAVMLPGGEGVRTPSGRRLMKPADPSFVSRHGLSTLVLPRPALHRALYDALPADCVRTGTEVLRLAGPPAGPVEVSCRDAAGEHTVPAGLVVAADGTHSRIRRALWPAVAAPAYSGHSVWRGIARLDRSEPGGTTWGCGQEFGRMPLRDGRVYWYAVANTPPGRRHPDELAEVVRRFGTWHHPIPALLRATPADEVLHHDVFELAQPLPGYAKGVTALLGDAAHAMTSDLGQGACQALEDAVVLGAELAADSDVPTALARYDAQRRPRAQTVVEASRRMGRLKLRERWWDVLMRNALISVMPPRAGEKAMARIGDWHPPALPAREAP	MTFLFKEFKGVFKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFGIAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIEILKQAIKDIPCHFNQRIKRIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKEEYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDNIRNEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVATQIKMKSWTKGRIALVGDSGYCSTALSGQGTTTALVGAYILAGELKAANGNHITAFERYNMLLHPFVEANQELGAWINETFLLEDAVSKEAVEARTDNIIKKISAISNVIKLPEYSAYK	99.50	gnl|BL_ORD_ID|2720|hsp_num:0	3284			33	1062	tetracycline; oxytetracycline
BGC0000242.1|Lysolipin_29 # 21469 # 22875 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=AGAGG;rbs_spacer=7bp;gc_cont=0.732	BGC0000242.1|Lysolipin_29 	21469	22875	-	Loose	900	75.0998	norB	23.38	3000421	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAACATAGCGCCGCAGCCCGATGCGGCAACCCCCGCCACCGCCGCGCGCGGCGACCGGGCCACCCCGCTGATCGCCGCACTGGTACTGGCGGCGGTCGCCTGCCAGCTGTGCATCTCCATGCCCACCCCCGCACTGCCCGACATCGCGGCCACCCTGCACACCACCACGGACGTGATCGGCCTGGCACAGGCGCTGTTCTTCCTGCTCGGCGGGCTGCTGTCGGTGATCATGGCAGCGTGCAGCGACTACGGCAACGCCCGCACCCTGATGGCCGTCTCCCTGGTGCTCGCCGTGGCCGGCTCGCTGGTCGCCGCGGCGGCGCCGGGGGTCGCGGTGTTCGTGGTGGGCCGGGCGCTGCAGGCCACGGCCACCGCCGTCTTCCCGGTCGCGCTGCGGGTGCTGCGGCAGACCCTGCCGCCCGGCCTGTTCGGGCGTGCCATGGGCATCATCACCGCCGCGAACGGCGGCATCGTCGGGCTGGACGGCCTGCTGTCCGGGTGGCTCACCGACACCTACGGCTACCGCTCGGTGTTCCTGGTGATGGCCGGCTTCGGCGCCGTCACCACTGTGGTGGTGCTGCGTGTCGTACCGGATCTGCGGCAGCGGCCCGCCGGGCGGCTGGACTGGGCCGGACTGGTCGTGCTGTCCCTCGGCCTGGCCTGCGTGGAGCTGGGCATCGGCATGGCCGGGAGGGCCCACGCGGGGGTGACGCTGGGCACGGTGGCGGCCGGGGTGGTGCTGTTCGCGGTGTTCTGGCGGGTGGAATCCGGCCGGGCGCACGCGCTGCTCCCCCCGTCCTACCTGAAATCCCGTCAGGCCTGGCCGGTGCTGGTCACCTCGGTACTGGCCTGCGCCGGCATGCTGAGCACCGTCAACTACGTGGTGCCGGTGTTCAGCCGTTCCGCGGACGCCGGCTACGGACTGTCGGCGACCTTCGCCGCACTGCTGTTCATCGTGCCGGTATGCCTGGTCAACGTGGTGTTCGCGCCCGTCGCGGGCGCCCTGGCACCGCGGGTGGGCTGGCGGCGCATGCTGCGGCTGTCCATGGCGGTGACCGTGCCGGTGCTGGTCTGCCTGGGCCTGGGCCTCGGATCGCGCTGGGTGACGTTCACCCTGGTCGTCCTGGTCGGCTTCGGGCTGGCCGGTGCGCTGACCCCGCTCAACGGGCTCAGCGCCATCCTCGCCGCGCCGAACAACCCCGGCCTGCTGCCCGGTGTCAACGCCGCCGCCTACGGCGTCGGCTCCTCGCTGGGCATCGCGATGGCCTCGCAACTGCTGGGCGACCGGGCGGGCGCCGCCGACTACCACCACGCCGTGTGGGTGGCCGCCGGGGTCGTCGCCCTCGGCTTCCTCAGCTCGCTGCTGATCACCGGGCGGGCCGGCGAACACGGCGAGAAGGTGTGA	MNIAPQPDAATPATAARGDRATPLIAALVLAAVACQLCISMPTPALPDIAATLHTTTDVIGLAQALFFLLGGLLSVIMAACSDYGNARTLMAVSLVLAVAGSLVAAAAPGVAVFVVGRALQATATAVFPVALRVLRQTLPPGLFGRAMGIITAANGGIVGLDGLLSGWLTDTYGYRSVFLVMAGFGAVTTVVVLRVVPDLRQRPAGRLDWAGLVVLSLGLACVELGIGMAGRAHAGVTLGTVAAGVVLFAVFWRVESGRAHALLPPSYLKSRQAWPVLVTSVLACAGMLSTVNYVVPVFSRSADAGYGLSATFAALLFIVPVCLVNVVFAPVAGALAPRVGWRRMLRLSMAVTVPVLVCLGLGLGSRWVTFTLVVLVGFGLAGALTPLNGLSAILAAPNNPGLLPGVNAAAYGVGSSLGIAMASQLLGDRAGAADYHHAVWVAAGVVALGFLSSLLITGRAGEHGEKV	MTSTAYKGTNKLIVGIVFGVITFWLFAQSMVNIVPAVQSDLGISSDLLSIAISLTALFSGIFIVVAGGMADKFGRVKLTYIGLILSIIGSLLLVVTQGSTLLIIGRIIQGLSAACIMPATLALMKTYFDGADRQRALSYWSIGSWGGSGICSFAGGAIATYMGWRWIFIISIVFALLGMLLIKGTPESKVVQNTKAKFDSFGLVLFVIAMVCLNLIITRGATFGWTSPITITMLVVFLVSAGLFFRVELRQANGFIDFSLFKNKAYTGATLSNFLLNAAAGTLVVANTYVQIGRGFTAFQSGLLSIGYLVCVLGMIRIGEKILQRVGARKPMILGSGITAVGIALMALTFIPGTLYTVLVFIGFALFGIGLGMYATPSTDTAISNAPEDKVGVASGIYKMASSLGGSFGVAISATIYGVIALSGNIDLAAMVGLLTNVGFCVVSLISVAITTPSAKKALELKAAKE	100.43	gnl|BL_ORD_ID|1078|hsp_num:0	1167			6	1254	ciprofloxacin; moxifloxacin; norfloxacin; sparfloxacin
BGC0000242.1|Lysolipin_30 # 22945 # 23658 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=10bp;gc_cont=0.768	BGC0000242.1|Lysolipin_30 	22945	23658	-	Loose	470	27.335	sdiA	32.47	3000826	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAGCTCCCAACTGGCCTTCTCCCGCCCCCGCACCCTCCCGGTCGCCTGGTAGCCGGCATGCTCAGCGACGACCTGCGGGAACTGGCCCGTCCGCTGGTGGCCGAAGTGACCGAGCACCCGTTCTGGGCGGGACTGCGCGACGGCACGCTGCCCGGCGAGGCGCTGGTGCGCTTCGTGGAACAGGACACCGGCCACCTGCTGCCCTGCTTCGGCCGCGCGTTCGCCCGGTGCGCGGCGGTCACCGAGGACGACGGTCACGCCCGCCTGCTGCTGCGGTGCGCCGCCGAAACGGTCGCCTCCGCGCCGCGGCTGCGCGAGACCCTCGCGGACATGGCGCCCCGCCTGGGGGTTCGGCCGCCCGCCTCGCCGGTGCCCGCGCACCCGGCCACGCGCGGCCAGTGCGCGGCGGTGACCGCCGCCGCGGCCACCTCGTGGGCGGCCGGCATCGGCGCCTTGCTGCCCTTCATGGTCTTCCACCTCGAGGTGTGCCGGGACCTCGCCGCCGGGCAGCCGCCCGCTTCCCGCTACCGGCCGTGGACCGACGCCTACCAGCCCGGCGAGGGCACCTGGTCCGCGGTGCGCGCGGTGCTGGCCATGGTCGACGAGTTCGGGGCCGGTGCCACCGCGGCGCAGCGCGCCGAGCTCGCCGACTGGTTCTGCCACGCCGCCCGGCACGAGTGGGCGTTCGCCGAGGCGGCCCTGTCCCTGTGA	MELPTGLLPPPHPPGRLVAGMLSDDLRELARPLVAEVTEHPFWAGLRDGTLPGEALVRFVEQDTGHLLPCFGRAFARCAAVTEDDGHARLLLRCAAETVASAPRLRETLADMAPRLGVRPPASPVPAHPATRGQCAAVTAAAATSWAAGIGALLPFMVFHLEVCRDLAAGQPPASRYRPWTDAYQPGEGTWSAVRAVLAMVDEFGAGATAAQRAELADWFCHAARHEWAFAEAALSL	MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLRTTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAKAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI	98.75	gnl|BL_ORD_ID|207|hsp_num:0	228			339	534	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000242.1|Lysolipin_32 # 24844 # 25902 # -1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=AGGGG;rbs_spacer=9bp;gc_cont=0.723	BGC0000242.1|Lysolipin_32 	24844	25902	-	Loose	556	28.8758	erm(32)	38.71	3004592	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAATGACGACGCGTCACCGCAGACGGGCGTCCTGTCCTGGTTCCCGGTCGGATTGCCGCCCCGGCAGCGGGTGATCGGCCTCTTCGTGGCCAAGTGGACGATCGGCGCGCTGCGCCCGCTGGTGCAGCTGAAGGTGCCGGACCTGCTGGCCGGCGGTCCGCGCACCGCCGCCGAGCTGGCCGCGGCCACCGGCACCGACGCCGACGGGCTGTACCGGCTGCTGCGGGCCGTCGCGGGCGCCGGGATCCTGCGCGAGGACGCCGAGGGCCGGTTCGCCCTCACCCCGGCCGCGGAGGGCCTGCGCTCCGATGCCGAGGACGGCGTGCGGGAGATGTTCCTGTTCGCCTGCGACCCGATGATGTGGCGGCCCTACGAGGACCTGCTGCACACCGTGCGCACCGGACAGCCCTCCTTCGACCGCGCGTTCGGGATGTCCTTCTTCGACTACCTGCGGGCCGACCCGGACAGCGCCCGGCTGTTCGACCAGGCCATGGTGCAGAACCACTACCCGGGAACCGACCGCATCTTCGAGGAGTTCGACTTCTCCCGCTTCCCCCGCATCGCGGACGTCGGCGGCGGACGCGGCCAGTTCCTCGCCGAGGTGCTCAGCCGCCATCCGGACTGCTCGGGCGCGGTGTGCGACCAGGCACAGGTGATCGCGGACGCCAAGGCGGAGTTCGAGCGGCGCGGGGTGGCCGACCGGGCGTCCGTGGTGGAGACCGACTTCTTCACCCGTGTGCCCGCCGGTTTCGACGCCTACTTCATCAAACACACCCTGCACAACTGGGACGACCGTGACGCGGTGCGGATCCTCACCCGGGTCCGTGAGGCGATCGGCGACCGCGGCGCGGCCCGGCTGCTCATCGTGGACATGCTGCTGGCCGGTCCCGGCGAGTGGGACCTCGGCAAGCTCACCGACGTCGAGATGATGGCCGCGCTCGGCGGACGCGAACGCGACCGCCAGGAGTGGGACCGGGTGGCCGCCGCGGCAGGCTTCGCCCCGGCCAACGACCCCCCGCCCAACGGCCTCGCCCTACTGGAGTACCGCCCGGTCTGA	MNDDASPQTGVLSWFPVGLPPRQRVIGLFVAKWTIGALRPLVQLKVPDLLAGGPRTAAELAAATGTDADGLYRLLRAVAGAGILREDAEGRFALTPAAEGLRSDAEDGVREMFLFACDPMMWRPYEDLLHTVRTGQPSFDRAFGMSFFDYLRADPDSARLFDQAMVQNHYPGTDRIFEEFDFSRFPRIADVGGGRGQFLAEVLSRHPDCSGAVCDQAQVIADAKAEFERRGVADRASVVETDFFTRVPAGFDAYFIKHTLHNWDDRDAVRILTRVREAIGDRGAARLLIVDMLLAGPGEWDLGKLTDVEMMAALGGRERDRQEWDRVAAAAGFAPANDPPPNGLALLEYRPV	MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAARAALLDSGHYAPLTERLAGTARRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLDMSKPAVRRAARAHPRASSAVADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLLVVTPQQDHLAELVDALGLLRVRDHKEGRLAEQLAPHFEAVGQERLRTTLRLDHDALGRVVAMGPSSWHQDPDELARRIAELPGIHEVTLSVTFTVCRPLP	125.71	gnl|BL_ORD_ID|2699|hsp_num:0	3294			276	369	narbomycin; methymycin; pikromycin
BGC0000242.1|Lysolipin_33 # 25895 # 27118 # -1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.712	BGC0000242.1|Lysolipin_33 	25895	27118	-	Loose	50	30.0314	vanW gene in vanB cluster	44.44	3002964	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	ATGCGGGACATCGACCTGATGGACGCCGGCGCCTTCACCGCGGGCGTGCCGTACGACTACTTCCGGCACCTGCGCGGCCTGCCCGGGCTGCACCGGGCGAAGGACGCGGAGGGCTACGACTTCTGGTACCTGGTGCGCCACGCGGACGTGGCGCGCGCCTCCAAGGACACCGACACCTTCCGCTCCGGTCCCAGCACCATGACCTCGGTGCGCCAGGACAGCACCGGCCTGCCGCTGATCTCGTTCCTGGACGCCCCGGAGCACTCCCGGCTGCGCCGGCTGGTCGCCAAGGGCTTCACCCCGGCCCGGCTGGCCGCCCTGGAGCAGCCGGTGGCCGGCATCCTGCGGCGCATCCTCGACGACGTGACGGCCAAGGACGAGTTCGACCTCGCCGAGGACATCGCCATGCAGCTGCCGATGGAGGTGCTCACCGAACTCATCGGCGTCCCGGCCGGGGAACGCGACCAGATCATCGAGTGGGGCCGCAGCACCGTCAACCTCGGCGACCCCGGCTACCGGCACAGCACGCCGGAGAAGGCCGTCGCCGCGTTCCAGAACCTGATGGCCTACTTCCGGGAACTGGCCGAGCGGCGCGCCGGGAAACCGGCCGACGACCTGTTCTCGGTGCTGCTCGCCGTGACGGACAAGGACGACAGCCGTCTCGAACCGCAGGAGATCGCGCTGTTCGCCACCACGCTGATCGGCGCGGGCAGCGAGACGACGTACGGTTCCATCACCGGGGGAGTGCTGGGCCTGCTGGACCGCCCCGACCAGGTGGCCCTGCTGCGCCGAAGGCGCGAGCTGATCCCCGCCGCGGTGGACGAGATCGTCCGCTGGGTCACGCCCGTCACCCACTTCGCCCGGCAGGTCGCCAAGGACACCGAGATCGGCGGCCAGTCCATCGCGGCGGGGGAGCGCGTGGTGCTGTGGTACACCTCCGCCAACCGCGACGAGTCGGTGTTCGACCGGCCCGACGAACTCCTGGTGACGCGCCGCCCCAACCCGCACGTGTCGTTCGGCGGCGGCGGCCCGCACGTGTGCATCGGCCGCGGTCTGGCCGTGCTGGAACTGCGGCTGTTCCTGGAAGCCGTCATCGACCGGCTGCCCCGCCTGGAACTGACCGGCGAGCCGGTGCGCAGCGCCACGAACTTCATGAACAGCTTCCGCTACGTGCCCGCCCGGTTCCGCCGGACCGGCGCAGGAGGGGTGAGAACCGATGAATGA	MRDIDLMDAGAFTAGVPYDYFRHLRGLPGLHRAKDAEGYDFWYLVRHADVARASKDTDTFRSGPSTMTSVRQDSTGLPLISFLDAPEHSRLRRLVAKGFTPARLAALEQPVAGILRRILDDVTAKDEFDLAEDIAMQLPMEVLTELIGVPAGERDQIIEWGRSTVNLGDPGYRHSTPEKAVAAFQNLMAYFRELAERRAGKPADDLFSVLLAVTDKDDSRLEPQEIALFATTLIGAGSETTYGSITGGVLGLLDRPDQVALLRRRRELIPAAVDEIVRWVTPVTHFARQVAKDTEIGGQSIAAGERVVLWYTSANRDESVFDRPDELLVTRRPNPHVSFGGGGPHVCIGRGLAVLELRLFLEAVIDRLPRLELTGEPVRSATNFMNSFRYVPARFRRTGAGGVRTDE	MNRKRLTQRFPFLLPMRQAQRKICFYAGMRFDGCCYAQTIGEKTLPYLLFETDCALYNHNTGFDMIYQENKVFNLKLAAKTLNGLLIKPGETFSFWRLVRHADKDTPYKDGLTVANGKLTTMSGGGMCQMSNLLFWVFLHTPLTIIQRSGHVVKEFPEPNSDEIKGVDATISEGWIDLKVRNDTDCTYQIWVTLDDEKIIGQVFADKQPQALYKIANGSIQYVRESGGIYEYAKVERMQVALGTGEIIDCKLLYTNKCKICYPLPESVDIQEANQ	148.00	gnl|BL_ORD_ID|4678|hsp_num:0	1036			261	369	vancomycin
BGC0000242.1|Lysolipin_34 # 27123 # 28151 # -1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.700	BGC0000242.1|Lysolipin_34 	27123	28151	-	Loose	500	28.8758	chrB	23.42	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGACGGGCACTTCCGTGCACGACCCGGGCGACACCGCCACCCCTGCCGGGATTCTGCGCTTGGCCAATGCCTTCGGCGACGCCAAGGCAGTTCTCACCGCCGTGGAACTGGGGCTGTTCACCGCGTTGAGCAGCCGGGGGCCGGCCACCCGGGAGGAGATCCGCGCCGAACTGGGGTTGCACGGCCGGGGGCTCGCCGACTGGCTCGACCTGCTGGTGGCCCTGGGCCTGCTGGCACGCGACGGCGACCGGTACCGCAACGCCTCCGGCGCGGACGCCTACCTGGTCAAGGGCAAGCAGCAGTACATCGGCGGTTTCCTCGAGCGCTCCAACCGGAACCTGTACCCGGCCTGGGGCAGGCTCACCGAGGCGCTGCGCACCGGCAAGCCGCAGGCGGGCGGCGACTTCTTCACGATGATCGACAACCCGGTCCTTCTCGCCCAGTTCGCCGACATGATGGACGCCCTCACGCGGGTGCTGGGCCCGCAGCTCATCGAGGCCTACGACGGCTGGGGCGACTACCGCTCGGTGCTGGACCTGGGCGGCTGCCGCGGCAACATGGCCGCGCAGATCGTCGCGGCCCACCCCGGCCTGACCGGCCTGGTCTTCGACCTGCCGCAGTTGCGGCCGCTGTTCGACGAGAAGATGGCCGAGTACGGGCTCACCGGGAAGGTCACCTTCCACGCCGGCGACTTCTTCGCCGACCCGCTTCCGTGCGCCGACATCGTGATGTACGGCCACGCGCTGCACGACTGGGACGCCGACCAGCGCGGCTTTCTGATCAACAAGGCGTTCGGCAGCGTCAACCCCGGCGGGGTGCTGCTGGTCTACGACCGCATGCTCGACAACGACCCCAGCCACGTCGAGAACCTGGTGATCAGCCTCGACATGCTGCTGGTGACCGAGGGCGGCTCGGAGTACACCGTCGACGAGGTGCGCGCACACGCCGAGGCGGCCGGTTTCGCCTCCGTCACCGCCCGCCCGCTCGGCGACTACGACACCCTGGTCGTCTGCCGCAAGGCGGCCTAG	MTGTSVHDPGDTATPAGILRLANAFGDAKAVLTAVELGLFTALSSRGPATREEIRAELGLHGRGLADWLDLLVALGLLARDGDRYRNASGADAYLVKGKQQYIGGFLERSNRNLYPAWGRLTEALRTGKPQAGGDFFTMIDNPVLLAQFADMMDALTRVLGPQLIEAYDGWGDYRSVLDLGGCRGNMAAQIVAAHPGLTGLVFDLPQLRPLFDEKMAEYGLTGKVTFHAGDFFADPLPCADIVMYGHALHDWDADQRGFLINKAFGSVNPGGVLLVYDRMLDNDPSHVENLVISLDMLLVTEGGSEYTVDEVRAHAEAAGFASVTARPLGDYDTLVVCRKAA	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	122.14	gnl|BL_ORD_ID|274|hsp_num:0	305			273	678	tylosin; chalcomycin; mycinamicin
BGC0000242.1|Lysolipin_35 # 28363 # 29988 # 1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=GAGGGA;rbs_spacer=9bp;gc_cont=0.734	BGC0000242.1|Lysolipin_35 	28363	29988	+	Loose	550	139.813	Nocardia farcinica rox	35.08	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGCTGACGTGAGTATCCCGGTGCTGGTGGTGGGCGGTGGCCCGGTCGGGCTGTCCACCGCGCTGTTCCTGGGCCGCCATGGCGTGCCCACCATGCTCGTGGAGAAACGTGACGCGACCTCGATGCTGCCCCGCGCGCCGGGGCTGCAGGCGCGCACGATGGAGCTCTTCCGCGCCGCCGGCTTCCACCGGGAGGTGCGGGCGCTGGAGATGGGCGACTCCCATCCCTACTTCGAGGGCGGCATCATCCAGACCTCGACGTTCTCCAGGATCGATGACGCGATCACCCTGGAGGCGCCCTCGCTGGACGGTCCGCGCATCAGCCCGGAACGCGTGATGGGCTGCGGCCAGGACCGCTACGAGCGGGTGCTGGTCGCCAAGGCGCGGGAGAACGGCTGCGACGTCCGCTTCGCCACCCGGCTGCTGGCCCTGACCCAGGACGAGGACAGGGTGACCGCGGTCATCGAGGACCGGGACGGGACGCAGCACACCGTCACCGCCCGGTACGCGGTGGCCGCGGACGGCGCCAGCAGCTTCGTACGCCGCACGCTCGGCGTGCGACGGCACGGCCGCGGCACCGTGTTCAACGCGCTGAGCATCTACTTCCGGGCGCCCCGGCTGGAGGGGATCCTGAAGGACCGCAAGTTCATCCTGTGCTACGCCACGGCCGCCCGCGGCACCCTGATGAGCCTGTCCCGGCTGCACGGCTGCGATCCGTGGCTGGCCACCCCGCTGTACTTCCCGGACAAGGGCGAGAAACCGGAGGACTTCACCGACGAGCGCTGCGTGGACATCATCCGCACCGCCGCCGGCGTCGACGACCTGGCCGTCGAGGTGGTGTGGAAGGTGCCGTGGCAGGGCTCGCAGCTGGTGGCCGAGACGTTCCGGGTGGGCCGGGTGTTCCTGGCCGGCGACGCCGCCCACGTCCACCCGCCGGCGGGCGGCTTCGGCGCCAACACCGGCATCCACGACGCGCACAACCTGGCCTGGAAACTCGCCGCGGTGCTGCGCGGCTGGGCGGGCCCGGCGCTGCTGGACACCTACGACGCCGAACGGCGCCGGGTCGGCGAGGCGATGGCCGAGCAGGCGATGATCCGCAACCGGATCCGCCACGGCTACGCCGACGAGGAGACCAGGGCGGCCATGGTGGACGACATCATCATCACCCTGGGCTACCGGTACCGCTCCAGCGCCGTCCCCGGCGGCTTCGACAGCGCGCCGGTGCTCACCCCGCGGCTGGAGCTGTCCGGCGAGCCGGGCACCCGGGCGCCGCACGTGTGGCTCGACCGGGACGGCGAGCGGATCTCCACCATCGACCTGTTCTGGGACGCCTACGTGGTGCTGACCGGCTCGCGGGGCGGCCCGTGGGCGGCGGCGGCCGAGCGCGCCGCGGCCCGGCTGGGCCTGCCGGTGCGCACCCATGTCATCGGCCCGCAGGGCTTGCGGCCCGTCGAGTGGGACTGGGCGCAGGCGTACGGCGTCACCGACAGCGGCGCGGTGCTGGTGCGGCCGGACGCCTTCGTCGCCTGGCGCTCGCCCGGCCTGGCCGCCGACCCCGTGGCGGAGCTGACCTCGGTGCTGGGCCGGGCGGCCGGCTTCACGACGCTGGTCGGGGAGGCACGATGA	MADVSIPVLVVGGGPVGLSTALFLGRHGVPTMLVEKRDATSMLPRAPGLQARTMELFRAAGFHREVRALEMGDSHPYFEGGIIQTSTFSRIDDAITLEAPSLDGPRISPERVMGCGQDRYERVLVAKARENGCDVRFATRLLALTQDEDRVTAVIEDRDGTQHTVTARYAVAADGASSFVRRTLGVRRHGRGTVFNALSIYFRAPRLEGILKDRKFILCYATAARGTLMSLSRLHGCDPWLATPLYFPDKGEKPEDFTDERCVDIIRTAAGVDDLAVEVVWKVPWQGSQLVAETFRVGRVFLAGDAAHVHPPAGGFGANTGIHDAHNLAWKLAAVLRGWAGPALLDTYDAERRRVGEAMAEQAMIRNRIRHGYADEETRAAMVDDIIITLGYRYRSSAVPGGFDSAPVLTPRLELSGEPGTRAPHVWLDRDGERISTIDLFWDAYVVLTGSRGGPWAAAAERAAARLGLPVRTHVIGPQGLRPVEWDWAQAYGVTDSGAVLVRPDAFVAWRSPGLAADPVAELTSVLGRAAGFTTLVGEAR	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	114.38	gnl|BL_ORD_ID|4834|hsp_num:0	5821			3	978	rifampin
BGC0000242.1|Lysolipin_36 # 29985 # 31001 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=4bp;gc_cont=0.719	BGC0000242.1|Lysolipin_36 	29985	31001	+	Loose	800	27.7202	APH(4)-Ib	51.85	3002656	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(4)	ATGAGCGAGCGGCTCGCCCCCGGCGCCCTGATGGAGACCGCGATGGCCTTCCAGACCGCGAAGCTGGTGCTGACCGGTGTGCGGCTGGGGCTGTACGACCTGCTGGCGAAGGCACCCGCCGACGAGGCGACGGTACGCGCCGAGCTGGGCCTGCACGCGCGCGGCACCGGGCACTTCCTGGCCGCGCTCGCCGAGCTGGGGGTCATCGAGGAGGAGGGCGGCGTCTACCGCAACGGTGCCGCCGCGTCCGCCTGCCTGGTGTCCGGCGCACCGGCGTACCTGGGCGGCTTCCTGCACATGGCCGACCAAGTGATGTACCCGGCGTGGGAGCGCCTCGACGCGTCGTTGCGCAGCGGCGAGCCGCAGGCCGCCACCTACACCGGCTCGGACATGTTCGGCCAGCTGTACGGGGACGACGGCAAGCAGTCGGACTTCATCCGCATGGCCGAGGACGCCAGCCGCCCCCTGATCCCGGCCCTGGTGGAGGCGTTCGACTGGGCGGCGTACAACTCGGTGCTGGAACTGGGCGGCTGCCGCGGCAACGTGCTGGCCCACCTGGTCGGGGCGCATCCGCATCTGACGGCCACCGTACTGGACCTGCCGCAGCTCCAAGACGCCTTCACCGCCCACATGTCGGCGCTCGGCACGGCCGGGGCGGTCTCCTTCCACGCCGCGGACTTCTTCACCGACCCGCTGCCCGAGGCGGAGGTGGTGATGATCGGGCACTGCATGGTCGACTGGACCGACGAGCAGCGCCGGGCGCTGATCGCCAACGTCTTCCCGGCGGTCCGGCCGGGCGGCGCCTTCCTGATCTGGGACCCCATGCTGGTGCCCGGCCAGGACAGCTACCTGCGCAACCTGGTGCGCGGGCTGAACTTCCAGCTGATGACGCCGCAGGGCACCAACTACCGGGTCGACGCGTGCGTCGGCTGGCTGCGGGAGGCGGGCTTCACCGGTGTCACGCACCGCCCGCTCGGGCAGGACGTCACCTTGGTGACCGCGCGCAAACCCGCCTAG	MSERLAPGALMETAMAFQTAKLVLTGVRLGLYDLLAKAPADEATVRAELGLHARGTGHFLAALAELGVIEEEGGVYRNGAAASACLVSGAPAYLGGFLHMADQVMYPAWERLDASLRSGEPQAATYTGSDMFGQLYGDDGKQSDFIRMAEDASRPLIPALVEAFDWAAYNSVLELGGCRGNVLAHLVGAHPHLTATVLDLPQLQDAFTAHMSALGTAGAVSFHAADFFTDPLPEAEVVMIGHCMVDWTDEQRRALIANVFPAVRPGGAFLIWDPMLVPGQDSYLRNLVRGLNFQLMTPQGTNYRVDACVGWLREAGFTGVTHRPLGQDVTLVTARKPA	MLQTSKKKSGHDESWANADAHKWRGERKRDNRKIVLSGTTKLLFVAEEQFQLIPPPSYCVSLVPKLPSNVTQPLFEYCFAPRILFFYALKKMTQHTKLCKLSSLIWREMWAISSRLQWQCVCAARRITMRNGGWKFIEMLSCWSDMVHKHESVLISTLPSFINFLVGPFRSAGAEPGGMHRRVDPPRPLSPALIEAFDGVMQLSGAPSRGVTPTPRGPDALGRITDSRGGSEAGYRFNMCNRAVPSAALPIGEVLDIGEFSGKRTYLAAVHRAREQDLPETELPAVLQPCTGMAHAIAAADLSHTSGFAPFGPQGMGQETPWRDKRDCYFDPQVYYWLSQMGDTLRASVAQGFEKRMLWAEDCPEARHLRIHVKGSNAALPEPGPKTWAGDGSQAVWAGRLRPTQDSRYVVASIFPWRPW	80.48	gnl|BL_ORD_ID|1547|hsp_num:0	1681			549	615	hygromycin B
BGC0000242.1|Lysolipin_38 # 31496 # 32122 # -1 # ID=1_38;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.774	BGC0000242.1|Lysolipin_38 	31496	32122	-	Loose	200	30.0314	vanH gene in vanA cluster	27.84	3002942	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	GCGCTGCTCGCCAAGCAGCTCGCCACGGTCGACCACCTCTCCGGCGGCCGGCTGACCGTCGGCCTGGCGGCCGGGGACCGCAGGGACGACTTCCACGCCGCCGGGGCACGGTTCAGCCGGCGCGGGCGGCTGCTGGACACCGCCGTCGAGGAGATCCGCGCCGTGTGGGCGGGCCGCGGACCGGTGCCGGGCATCGGACCGCGTCCGCCCCGCGGCGGCCCGCCGCTGCTGTTCGGCGGGCACTCCCCGGCGGCCATGCGCCGCGCGGCCAGGTTCGGCGCCGGCTGGATCAGCGGCGGCAGCTCCGGCACCGCCTACCGCGACCTGGTGGCCCGGGCCCGCACCATCTGGGCCGACGAGGGCCGCACCGAGCCGCTGCGGGTGGTCTCGCTGGCCTACGTCTCGCTCGGCGCGGACGGCCGCGGCCACGCCGAGCGGTACCTGCGGGCCTATTACGCGTACATCGGCGCCAAGGCGGAGCAGGCCGTCGCCCGGGCCATCACCACCGAGGACCGGCTGCGCGAGGCCATTGCCGGCTATGCCGACGCCGGCTGCGACGAGCTGGTGCTCTTCCCCTGCTGCGGCGCCGCGCAACAGGCGGACCTCATCGCCGGAGCGCTGCCGTGA	ALLAKQLATVDHLSGGRLTVGLAAGDRRDDFHAAGARFSRRGRLLDTAVEEIRAVWAGRGPVPGIGPRPPRGGPPLLFGGHSPAAMRRAARFGAGWISGGSSGTAYRDLVARARTIWADEGRTEPLRVVSLAYVSLGADGRGHAERYLRAYYAYIGAKAEQAVARAITTEDRLREAIAGYADAGCDELVLFPCCGAAQQADLIAGALP	MNNIGITVYGCEQDEADAFHALSPRFGVMATIINANVSESNAKSAPFNQCISVGHKSEISASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGITVDNVAYSPDSVADYTMMLILMAVRNVKSIVRSVEKHDFRLDSDRGKVLSDMTVGVVGTGQIGKAVIERLRGFGCKVLAYSRSRSIEVNYVPFDELLQNSDIVTLHVPLNTDTHYIISHEQIQRMKQGAFLINTGRGPLVDTYELVKALENGKLGGAALDVLEGEEEFFYSDCTQKPIDNQFLLKLQRMPNVIITPHTAYYTEQALRDTVEKTIKNCLDFERRQEHE	64.60	gnl|BL_ORD_ID|4669|hsp_num:0	178			15	276	vancomycin; teicoplanin
BGC0000242.1|Lysolipin_20 # 12986 # 13669 # -1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=4bp;gc_cont=0.759	BGC0000242.1|Lysolipin_20 	12986	13669	-	Loose	660	26.1794	MexS	36.84	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGACCCGATCCGTACGGCCCTGGTGACCGGGGCCAACCGCGGCATAGGCCGCGCCACCGCCGCCGCCCTGCACGCGCTGGGCTGGCGGGTGGTGCTGGCGGCCCGGGACGCGGACGAGGCCGAGCGGGCGGCGGCCTCGCTCGGGCCCGGGGCGTCCGGCATCGCCTTGGACGTCACCTGCCCGCGGAGCGTGGCCCGCGCCGCCGGGCGGGCCGGCGAGGTGGACGCCCTGGTCAACAACGCCGGGGTGCTGCTCGACGCGGGCGCGGACCCGCTGTCGGTGCCCATCGAGGTGGTCCGCGCCACCCTGGAGGTCAACGTGCTCGGCGCCTGGCGGGTGTGCCGGCAGTTCGTACCCGGCATGGTGCGGCGCGGCTGGGGGCGCGTGGTGTTCGTCTCCAGCGGTACCGGCGCGTTCAGCAACGGCCTGTTCACCGGCACGCCCGCCTACTCGCTGTCCAAGACGGCCGTCAACGGCCTGACCACCCTTCTCGCCGCCCACACCAAGGGCACCGGAGTGCTGGTGAACGCCGTCAACCCGGGGCGCACCCGGACGCGGATGATGCCCGGCGCCGAACGCCCGCCCGAGGAGGCGGCCGGCGACATCGTGCACGCGCTCACCCTGCCCGACGACGGACCCACCGGTGTCTTCCTGCGGGAGCGCCGGGTGACGGACTGGTAG	VDPIRTALVTGANRGIGRATAAALHALGWRVVLAARDADEAERAAASLGPGASGIALDVTCPRSVARAAGRAGEVDALVNNAGVLLDAGADPLSVPIEVVRATLEVNVLGAWRVCRQFVPGMVRRGWGRVVFVSSGTGAFSNGLFTGTPAYSLSKTAVNGLTTLLAAHTKGTGVLVNAVNPGRTRTRMMPGAERPPEEAAGDIVHALTLPDDGPTGVFLRERRVTDW	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	66.96	gnl|BL_ORD_ID|1039|hsp_num:0	1041			438	552	ciprofloxacin; trimethoprim; chloramphenicol
